A primary role of the CSORDA Administrative Core is to provide an infrastructure for optimizing collaborative, multidisciplinary. Innovative research and to maintain excellence for addiction-related research, training and outreach. The Administrative Core provides programmatic structure, logistical support, and mediation of the Center's interactions with training programs, administrative offices, and scientific and governmental institutions. The Core is responsible for budgetary and scientific oversight of all CSORDA research as well as logistics relating to the Pilot Program. The Director of CSORDA, Dr. Chris Evans is the PI of the Administrative Core, and in his absence, the Associate Director, Dr. Nigel Maidment, serves in this capacity. The Core has a sophisticated Advisory Board to provide guidance on both administrative and scientific issues. The Core is staffed by Ms Polly Segal (35% effort), who is an experienced administrator performing an essential role in executing daily duties associated with the core. Responsibilities of the core include, but are not limited to: ? Coordination and evaluation of the Center's scientific directions, programmatic meetings, educational and outreach roles, progress and collaborative interactions. ? Overseeing operation of the Pilot Program;including advertising for potential grantees, evaluation and selection of proposals, and integration with ongoing research in CSORDA. ? Oversight and resolution of personnel issues including hiring, advancements and promotions, conflicts and recruitment. ? Support for publications, grant preparations, coordination of seminars and meetings, travel and purchasing. ? Budgetary preparation, prioritization of fiscal resources and monitoring. The Administrative Core is essential to the efficient operation of CSORDA.
The Administrative Core is essential to the operation of CSORDA that during the next funding cycle has the goal of discerning the opioid circuits that mediate addiction behaviors to identify new therapeutic targets for substance abuse.
|Erbs, Eric; Faget, Lauren; Scherrer, Gregory et al. (2015) A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct 220:677-702|
|Wang, Nan; Gray, Michelle; Lu, Xiao-Hong et al. (2014) Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Nat Med 20:536-41|
|Wassum, Kate M; Greenfield, Venuz Y; Linker, Kay E et al. (2014) Inflated reward value in early opiate withdrawal. Addict Biol :|
|Ivanov, Iliyan; Liu, Xun; Clerkin, Suzanne et al. (2014) Methylphenidate and brain activity in a reward/conflict paradigm: role of the insula in task performance. Eur Neuropsychopharmacol 24:897-906|
|Tsoa, Rosemarie W; Coskun, Volkan; Ho, Chi K et al. (2014) Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain. Proc Natl Acad Sci U S A 111:7444-9|
|Taylor, Anna M W; Murphy, Niall P; Evans, Christopher J et al. (2014) Correlation between ventral striatal catecholamine content and nociceptive thresholds in neuropathic mice. J Pain 15:878-85|
|Ostlund, Sean B; Kosheleff, Alisa R; Maidment, Nigel T (2014) Differential effects of systemic cholinergic receptor blockade on Pavlovian incentive motivation and goal-directed action selection. Neuropsychopharmacology 39:1490-7|
|Becker, Jérôme A J; Clesse, Daniel; Spiegelhalter, Coralie et al. (2014) Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology 39:2049-60|
|Pradhan, Amynah A; Smith, Monique L; McGuire, Brenna et al. (2014) Characterization of a novel model of chronic migraine. Pain 155:269-74|
|Liu, Hailiang; Chen, Yongchang; Niu, Yuyu et al. (2014) TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell 14:323-8|
Showing the most recent 10 out of 36 publications